FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973086136> ?p ?o ?g. }

• W2973086136 endingPage "6527" @default.
• W2973086136 startingPage "6519" @default.
• W2973086136 abstract "Abstract Background Bevacizumab improves symptoms via reducing the peritumoral edema and/or normalizing blood brain barrier, and occasionally via reducing the tumor size. However, the effect against active cystic components has not been documented yet. Materials and Methods Between 2008 and 2018, 139 patients with primary or metastatic brain tumors were treated with bevacizumab (BEV) in our institution. The images and symptoms before and after administration of BEV were examined, and changes in size of cysts were evaluated as follows: CR (complete disappearance), PR (reduction by ≥50%), MR (reduction by ≥25%), SD (size change <25%), PD (increase by ≥25%). The effect of BEV on tumor itself was determined according to Response Assessment in Neuro‐Oncology criteria. Results Of the 139 patients, 21 (15.1%) had cystic components. The best responses of cysts to BEV treatment were as follows: CR 6, PR 7, MR 4, SD 4. The group of patients with progressively increasing cysts prior to BEV treatment had significant cyst size reduction compared to stable cyst size groups, at initial imaging after BEV (mean 62.6% vs 22.5%, P = .0055) and at best response timing (mean 76.3% vs 32.8%, P = .0050). Patients with cysts showed significant improvement in symptoms after the treatment with BEV compared to patients without cysts ( P = .0033). However, response rate was not different between patients with or without cysts. Overall survival after starting BEV was not different between glioblastoma patients with or without cysts. Conclusion Bevacizumab is effective against progressively increasing cysts. Although cysts reduction effect and tumor response and/or overall survival are independent, BEV may be effective in patients who are symptomatic due to cyst enlargement." @default.
• W2973086136 created "2019-09-19" @default.
• W2973086136 creator A5002468717 @default.
• W2973086136 creator A5008190073 @default.
• W2973086136 creator A5018115431 @default.
• W2973086136 creator A5033949642 @default.
• W2973086136 creator A5050723918 @default.
• W2973086136 creator A5059190043 @default.
• W2973086136 creator A5061665880 @default.
• W2973086136 creator A5063374795 @default.
• W2973086136 creator A5064677296 @default.
• W2973086136 creator A5070079124 @default.
• W2973086136 creator A5070746851 @default.
• W2973086136 creator A5071269946 @default.
• W2973086136 creator A5085065231 @default.
• W2973086136 date "2019-09-09" @default.
• W2973086136 modified "2023-10-16" @default.
• W2973086136 title "Effect of bevacizumab against cystic components of brain tumors" @default.
• W2973086136 cites W1990170360 @default.
• W2973086136 cites W1994062040 @default.
• W2973086136 cites W2016904444 @default.
• W2973086136 cites W2036259521 @default.
• W2973086136 cites W2056013092 @default.
• W2973086136 cites W2073972082 @default.
• W2973086136 cites W2081633887 @default.
• W2973086136 cites W2085381340 @default.
• W2973086136 cites W2085752449 @default.
• W2973086136 cites W2101219402 @default.
• W2973086136 cites W2104361887 @default.
• W2973086136 cites W2111996228 @default.
• W2973086136 cites W2121080406 @default.
• W2973086136 cites W2124561505 @default.
• W2973086136 cites W2124736921 @default.
• W2973086136 cites W2140704845 @default.
• W2973086136 cites W2149694415 @default.
• W2973086136 cites W2156330848 @default.
• W2973086136 cites W2165772224 @default.
• W2973086136 cites W238497424 @default.
• W2973086136 cites W2543372228 @default.
• W2973086136 cites W2600506014 @default.
• W2973086136 cites W2612201027 @default.
• W2973086136 cites W2719272910 @default.
• W2973086136 cites W2748749383 @default.
• W2973086136 cites W2762951373 @default.
• W2973086136 cites W2768388636 @default.
• W2973086136 cites W2781725933 @default.
• W2973086136 doi "https://doi.org/10.1002/cam4.2537" @default.
• W2973086136 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6825995" @default.
• W2973086136 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31498567" @default.
• W2973086136 hasPublicationYear "2019" @default.
• W2973086136 type Work @default.
• W2973086136 sameAs 2973086136 @default.
• W2973086136 citedByCount "4" @default.
• W2973086136 countsByYear W29730861362021 @default.
• W2973086136 countsByYear W29730861362022 @default.
• W2973086136 crossrefType "journal-article" @default.
• W2973086136 hasAuthorship W2973086136A5002468717 @default.
• W2973086136 hasAuthorship W2973086136A5008190073 @default.
• W2973086136 hasAuthorship W2973086136A5018115431 @default.
• W2973086136 hasAuthorship W2973086136A5033949642 @default.
• W2973086136 hasAuthorship W2973086136A5050723918 @default.
• W2973086136 hasAuthorship W2973086136A5059190043 @default.
• W2973086136 hasAuthorship W2973086136A5061665880 @default.
• W2973086136 hasAuthorship W2973086136A5063374795 @default.
• W2973086136 hasAuthorship W2973086136A5064677296 @default.
• W2973086136 hasAuthorship W2973086136A5070079124 @default.
• W2973086136 hasAuthorship W2973086136A5070746851 @default.
• W2973086136 hasAuthorship W2973086136A5071269946 @default.
• W2973086136 hasAuthorship W2973086136A5085065231 @default.
• W2973086136 hasBestOaLocation W29730861361 @default.
• W2973086136 hasConcept C126322002 @default.
• W2973086136 hasConcept C126838900 @default.
• W2973086136 hasConcept C2776194525 @default.
• W2973086136 hasConcept C2776694085 @default.
• W2973086136 hasConcept C2777802072 @default.
• W2973086136 hasConcept C2780597408 @default.
• W2973086136 hasConcept C502942594 @default.
• W2973086136 hasConcept C71924100 @default.
• W2973086136 hasConcept C90924648 @default.
• W2973086136 hasConceptScore W2973086136C126322002 @default.
• W2973086136 hasConceptScore W2973086136C126838900 @default.
• W2973086136 hasConceptScore W2973086136C2776194525 @default.
• W2973086136 hasConceptScore W2973086136C2776694085 @default.
• W2973086136 hasConceptScore W2973086136C2777802072 @default.
• W2973086136 hasConceptScore W2973086136C2780597408 @default.
• W2973086136 hasConceptScore W2973086136C502942594 @default.
• W2973086136 hasConceptScore W2973086136C71924100 @default.
• W2973086136 hasConceptScore W2973086136C90924648 @default.
• W2973086136 hasIssue "15" @default.
• W2973086136 hasLocation W29730861361 @default.
• W2973086136 hasLocation W29730861362 @default.
• W2973086136 hasLocation W29730861363 @default.
• W2973086136 hasLocation W29730861364 @default.
• W2973086136 hasOpenAccess W2973086136 @default.
• W2973086136 hasPrimaryLocation W29730861361 @default.
• W2973086136 hasRelatedWork W2123323025 @default.
• W2973086136 hasRelatedWork W2152323728 @default.
• W2973086136 hasRelatedWork W2336148609 @default.

• next